Electrophoresis of BRCA1 oncosuppressor

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 995-997

  Bernard Gallon, Dominique ^a   De Oliveira, Frederic ^a   Favy, David ^a   Hizel, Candan ^a   Maurizis, Jean Claude ^b   Rio, Pascale ^a,b   Bignon, Yves Jean ^a  

^a CENTRE JEAN PERRIN   (France)

^b INSERM   (France)

Author keywords

BRCA1; HBL100; Immunoprecipitation; MCF7; Western blot

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CELLULAR DISTRIBUTION; ELECTROPHORESIS; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031867433     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.995     Document Type: Article

References (20)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, MacClure M, Frye C, Mattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhasen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA-1. Science 266: 66-71, 1994.
2. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L, Fourquet A, Salmon RJ. Clough KB, Pouillard P, the Institut Curie Breast Cancer Group, Bonaiti-Pellié C and Thomas G: BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Am J Hum Genet 60: 1021-1030, 1997.
3. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett C, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Igiehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A and Wiseman R: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122, 1994.
4. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang M-CW, Hwang L-Y, Bowcock AM and Baer R: Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14: 430-447, 1996.
5. Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM and Parvin JD: BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 94: 5605-5610, 1997.
6. Chen Y, Chen C-F, Riley DJ, Allred DC, Chen P-L, von Hoff D, Osborne CK and Lee W-H: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791, 1995.
7. Chen Y, Farmer AA, Chen C-F, Jones DC, Chen P-L and Lee W-H: BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56: 3168-3172, 1996.
8. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S and Livingston DM: Location of BRCA 1 in human breast and ovarian cancer cells. Science 272: 123-124, 1996.
9. Wang H, Shao N, Ding QM, Cui J-Q, Reddy ESP and Rao VN: BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA la, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15: 143-157, 1997.
10. Jensen RA, Thompson ME, Jetton TL, Szabo CI, van der Meer R, Helou B, Tronick SR, Page DL, King M-C and Holt JT: BRCA1 is secreted and exhibits properties of a granin. Nat Genet 12: 303-308, 1996.
11. Soule HD, Vasquez J, Long A, Albert AS and Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416, 1973.
12. Gaffney EV, Pigott DA and Grimaldi MA: Human serum and the growth of human mammary cells. J Natl Cancer Inst 63: 913-918, 1979.
13. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A laboratory Manual. 2nd edition. Cold spring Harbor Laboratory Press, New York, pp18.60, 1989.
14. Bernard DJ, Maurizis J-C, Chassagne J, Chollet P and Plagne R: Comparison of Class II HLA antigen expression in normal and carcinomatous human breast cells. Cancer Res 45: 1152-1158, 1985.
15. Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Cough FJ, Wilson RB and Weber BL: Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 17: 444-452, 1997.
16. Wilson CA, Payton MN, Pekar SK, Zhang K, Pacifici RE, Gudas JL, Thukral S, Calzone FJ, Reese DM and Slamon DI: BRCA1 protein products: antibody specificity. Nat Genet 13: 264-265, 1996.
17. Bernard-Gallon DJ, Crespin NC, Maurizis J-C and Bignon Y-J: Cross-reaction between antibodies raised against the last 20 C-terminal amino acids of BRCA1 (C-20) and human EGF and EGF-R in MCF10a human mammary epithelial cell line. Int J Cancer 7: 123-126, 1997.
18. Jensen RA, Thompson ME, Jetton TI, van der Meer R, Helou B, Arteaga CL, Page DL, Holt JT, Gown AM. Skelly M, Ostermeyer B, Schieltz D, Szabo CI and King M-C: Reply. Nat Genet 13:269-272, 1996.
19. Chattergoon M, Boyer J and Weiner DB: Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J 11: 753-763, 1997.
20. Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA, Baird SM and Rhodes GH: Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 91: 9519-9523, 1994.